Lenacapavir

Global Fund and U.S. Expand Commitment to Long-Acting HIV Prevention as Country Rollout of Lenacapavir Accelerates

In Eswatini, an HIV Breakthrough Delivered

The Global Fund Welcomes Commitment by the United States to Expand Access to Lenacapavir

Global Fund Secures Access to Breakthrough HIV Prevention Drug Lenacapavir for Low- and Middle-Income Countries

Global Fund, PEPFAR Announce Coordinated Effort to Reach 2 Million People with Lenacapavir for PrEP to Significantly Reduce Global HIV Infections